INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 215 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070 | -12.9% | 2,750 | 0.0% | 0.00% | – |
| Q2 2023 | $1,228 | -45.5% | 2,750 | 0.0% | 0.00% | – |
| Q1 2023 | $2,255 | -47.4% | 2,750 | 0.0% | 0.00% | – |
| Q4 2022 | $4,290 | -14.2% | 2,750 | 0.0% | 0.00% | – |
| Q3 2022 | $5,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -50.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2022 | $10,000 | -28.6% | 2,750 | 0.0% | 0.00% | – |
| Q4 2021 | $14,000 | -30.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2021 | $20,000 | -20.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2021 | $25,000 | -3.8% | 2,750 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +8.3% | 2,750 | 0.0% | 0.00% | – |
| Q4 2020 | $24,000 | -25.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2020 | $32,000 | -56.8% | 2,750 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $74,000 | +270.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2020 | $20,000 | +122.2% | 2,750 | 0.0% | 0.00% | – |
| Q4 2019 | $9,000 | +50.0% | 2,750 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | -25.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2019 | $8,000 | -20.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2019 | $10,000 | -9.1% | 2,750 | 0.0% | 0.00% | – |
| Q4 2018 | $11,000 | -26.7% | 2,750 | 0.0% | 0.00% | – |
| Q3 2018 | $15,000 | +36.4% | 2,750 | 0.0% | 0.00% | – |
| Q2 2018 | $11,000 | -15.4% | 2,750 | 0.0% | 0.00% | – |
| Q1 2018 | $13,000 | +18.2% | 2,750 | 0.0% | 0.00% | – |
| Q4 2017 | $11,000 | -42.1% | 2,750 | 0.0% | 0.00% | – |
| Q4 2016 | $19,000 | -26.9% | 2,750 | 0.0% | 0.00% | – |
| Q3 2016 | $26,000 | +4.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2016 | $25,000 | +4.2% | 2,750 | 0.0% | 0.00% | – |
| Q1 2016 | $24,000 | +33.3% | 2,750 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | +12.5% | 2,750 | 0.0% | 0.00% | – |
| Q3 2015 | $16,000 | -27.3% | 2,750 | 0.0% | 0.00% | – |
| Q2 2015 | $22,000 | 0.0% | 2,750 | 0.0% | 0.00% | – |
| Q1 2015 | $22,000 | -12.0% | 2,750 | 0.0% | 0.00% | – |
| Q4 2014 | $25,000 | -7.4% | 2,750 | 0.0% | 0.00% | – |
| Q3 2014 | $27,000 | -10.0% | 2,750 | 0.0% | 0.00% | – |
| Q2 2014 | $30,000 | – | 2,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 648,800 | $1,920,000 | 1.55% |
| Round Table Services, LLC | 339,391 | $998,000 | 0.31% |
| ARK Investment Management | 3,955,017 | $11,628,000 | 0.29% |
| Nikko Asset Management Americas, Inc. | 4,884,100 | $14,359,000 | 0.28% |
| WASATCH ADVISORS LP | 6,735,726 | $19,803,000 | 0.19% |
| Cedar Brook Financial Partners, LLC | 41,500 | $122,000 | 0.06% |
| Unified Trust Company, N.A. | 15,716 | $46,000 | 0.03% |
| Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors | 13,500 | $40,000 | 0.03% |
| STONERIDGE INVESTMENT PARTNERS LLC | 16,914 | $50,000 | 0.02% |
| Sumitomo Mitsui Trust Holdings, Inc. | 4,884,100 | $14,359,000 | 0.01% |